282 related articles for article (PubMed ID: 21980336)
1. Isolation of a human anti-HIV gp41 membrane proximal region neutralizing antibody by antigen-specific single B cell sorting.
Morris L; Chen X; Alam M; Tomaras G; Zhang R; Marshall DJ; Chen B; Parks R; Foulger A; Jaeger F; Donathan M; Bilska M; Gray ES; Abdool Karim SS; Kepler TB; Whitesides J; Montefiori D; Moody MA; Liao HX; Haynes BF
PLoS One; 2011; 6(9):e23532. PubMed ID: 21980336
[TBL] [Abstract][Full Text] [Related]
2. Dependence on a variable residue limits the breadth of an HIV MPER neutralizing antibody, despite convergent evolution with broadly neutralizing antibodies.
Scheepers C; Kgagudi P; Mzindle N; Gray ES; Moyo-Gwete T; Lambson BE; Oosthuysen B; Mabvakure B; Garrett NJ; Abdool Karim SS; Morris L; Moore PL
PLoS Pathog; 2022 Sep; 18(9):e1010450. PubMed ID: 36054228
[TBL] [Abstract][Full Text] [Related]
3. Neutralizing epitopes in the membrane-proximal external region of HIV-1 gp41 are influenced by the transmembrane domain and the plasma membrane.
Montero M; Gulzar N; Klaric KA; Donald JE; Lepik C; Wu S; Tsai S; Julien JP; Hessell AJ; Wang S; Lu S; Burton DR; Pai EF; Degrado WF; Scott JK
J Virol; 2012 Mar; 86(6):2930-41. PubMed ID: 22238313
[TBL] [Abstract][Full Text] [Related]
4. Stable docking of neutralizing human immunodeficiency virus type 1 gp41 membrane-proximal external region monoclonal antibodies 2F5 and 4E10 is dependent on the membrane immersion depth of their epitope regions.
Dennison SM; Stewart SM; Stempel KC; Liao HX; Haynes BF; Alam SM
J Virol; 2009 Oct; 83(19):10211-23. PubMed ID: 19640992
[TBL] [Abstract][Full Text] [Related]
5. Analysis of the human immunodeficiency virus type 1 gp41 membrane proximal external region arrayed on hepatitis B surface antigen particles.
Phogat S; Svehla K; Tang M; Spadaccini A; Muller J; Mascola J; Berkower I; Wyatt R
Virology; 2008 Mar; 373(1):72-84. PubMed ID: 18155743
[TBL] [Abstract][Full Text] [Related]
6. Prolonged exposure of the HIV-1 gp41 membrane proximal region with L669S substitution.
Shen X; Dennison SM; Liu P; Gao F; Jaeger F; Montefiori DC; Verkoczy L; Haynes BF; Alam SM; Tomaras GD
Proc Natl Acad Sci U S A; 2010 Mar; 107(13):5972-7. PubMed ID: 20231447
[TBL] [Abstract][Full Text] [Related]
7. N-terminal residues of an HIV-1 gp41 membrane-proximal external region antigen influence broadly neutralizing 2F5-like antibodies.
Li D; Liu J; Zhang L; Xu T; Chen J; Wang L; Zhao Q
Virol Sin; 2015 Dec; 30(6):449-56. PubMed ID: 26715302
[TBL] [Abstract][Full Text] [Related]
8. Structure-guided alterations of the gp41-directed HIV-1 broadly neutralizing antibody 2F5 reveal new properties regarding its neutralizing function.
Guenaga J; Wyatt RT
PLoS Pathog; 2012; 8(7):e1002806. PubMed ID: 22829767
[TBL] [Abstract][Full Text] [Related]
9. Structural and Thermodynamic Basis of Epitope Binding by Neutralizing and Nonneutralizing Forms of the Anti-HIV-1 Antibody 4E10.
Rujas E; Gulzar N; Morante K; Tsumoto K; Scott JK; Nieva JL; Caaveiro JM
J Virol; 2015 Dec; 89(23):11975-89. PubMed ID: 26378169
[TBL] [Abstract][Full Text] [Related]
10. Estimating the probability of polyreactive antibodies 4E10 and 2F5 disabling a gp41 trimer after T cell-HIV adhesion.
Hu B; Liao HX; Alam SM; Goldstein B
PLoS Comput Biol; 2014 Jan; 10(1):e1003431. PubMed ID: 24499928
[TBL] [Abstract][Full Text] [Related]
11. Effect of diversity in gp41 membrane proximal external region of primary HIV-1 Indian subtype C sequences on interaction with broadly neutralizing antibodies 4E10 and 10E8.
Sutar J; Padwal V; Sonawani A; Nagar V; Patil P; Kulkarni B; Hingankar N; Deshpande S; Idicula-Thomas S; Jagtap D; Bhattacharya J; Bandivdekar A; Patel V
Virus Res; 2019 Nov; 273():197763. PubMed ID: 31553924
[TBL] [Abstract][Full Text] [Related]
12. Evolution of antibody landscape and viral envelope escape in an HIV-1 CRF02_AG infected patient with 4E10-like antibodies.
Dieltjens T; Heyndrickx L; Willems B; Gray E; Van Nieuwenhove L; Grupping K; Vanham G; Janssens W
Retrovirology; 2009 Dec; 6():113. PubMed ID: 20003438
[TBL] [Abstract][Full Text] [Related]
13. Induction of HIV neutralizing antibodies against the MPER of the HIV envelope protein by HA/gp41 chimeric protein-based DNA and VLP vaccines.
Ye L; Wen Z; Dong K; Wang X; Bu Z; Zhang H; Compans RW; Yang C
PLoS One; 2011; 6(5):e14813. PubMed ID: 21625584
[TBL] [Abstract][Full Text] [Related]
14. Anti-V3/Glycan and Anti-MPER Neutralizing Antibodies, but Not Anti-V2/Glycan Site Antibodies, Are Strongly Associated with Greater Anti-HIV-1 Neutralization Breadth and Potency.
Jacob RA; Moyo T; Schomaker M; Abrahams F; Grau Pujol B; Dorfman JR
J Virol; 2015 May; 89(10):5264-75. PubMed ID: 25673728
[TBL] [Abstract][Full Text] [Related]
15. Identification and characterization of a broadly cross-reactive HIV-1 human monoclonal antibody that binds to both gp120 and gp41.
Zhang MY; Yuan T; Li J; Rosa Borges A; Watkins JD; Guenaga J; Yang Z; Wang Y; Wilson R; Li Y; Polonis VR; Pincus SH; Ruprecht RM; Dimitrov DS
PLoS One; 2012; 7(9):e44241. PubMed ID: 22970187
[TBL] [Abstract][Full Text] [Related]
16. Anti-human immunodeficiency virus type 1 (HIV-1) antibodies 2F5 and 4E10 require surprisingly few crucial residues in the membrane-proximal external region of glycoprotein gp41 to neutralize HIV-1.
Zwick MB; Jensen R; Church S; Wang M; Stiegler G; Kunert R; Katinger H; Burton DR
J Virol; 2005 Jan; 79(2):1252-61. PubMed ID: 15613352
[TBL] [Abstract][Full Text] [Related]
17. HIV-1 gp41 core with exposed membrane-proximal external region inducing broad HIV-1 neutralizing antibodies.
Wang J; Tong P; Lu L; Zhou L; Xu L; Jiang S; Chen YH
PLoS One; 2011 Mar; 6(3):e18233. PubMed ID: 21483871
[TBL] [Abstract][Full Text] [Related]
18. Mechanism of HIV-1 neutralization by antibodies targeting a membrane-proximal region of gp41.
Chen J; Frey G; Peng H; Rits-Volloch S; Garrity J; Seaman MS; Chen B
J Virol; 2014 Jan; 88(2):1249-58. PubMed ID: 24227838
[TBL] [Abstract][Full Text] [Related]
19. Bovine papillomavirus-like particles presenting conserved epitopes from membrane-proximal external region of HIV-1 gp41 induced mucosal and systemic antibodies.
Zhai Y; Zhong Z; Zariffard M; Spear GT; Qiao L
Vaccine; 2013 Nov; 31(46):5422-9. PubMed ID: 24055348
[TBL] [Abstract][Full Text] [Related]
20. An affinity-enhanced neutralizing antibody against the membrane-proximal external region of human immunodeficiency virus type 1 gp41 recognizes an epitope between those of 2F5 and 4E10.
Nelson JD; Brunel FM; Jensen R; Crooks ET; Cardoso RM; Wang M; Hessell A; Wilson IA; Binley JM; Dawson PE; Burton DR; Zwick MB
J Virol; 2007 Apr; 81(8):4033-43. PubMed ID: 17287272
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
